170 related articles for article (PubMed ID: 10583711)
21. Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liver.
Rudling M; Angelin B; Ståhle L; Reihnér E; Sahlin S; Olivecrona H; Björkhem I; Einarsson C
J Clin Endocrinol Metab; 2002 Sep; 87(9):4307-13. PubMed ID: 12213890
[TBL] [Abstract][Full Text] [Related]
22. Role of hydrophilic bile acids and of sterols on cholelithiasis in the hamster.
Singhal AK; Cohen BI; Finver-Sadowsky J; McSherry CK; Mosbach EH
J Lipid Res; 1984 Jun; 25(6):564-70. PubMed ID: 6547738
[TBL] [Abstract][Full Text] [Related]
23. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
[TBL] [Abstract][Full Text] [Related]
24. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients.
Reihnér E; Angelin B; Rudling M; Ewerth S; Björkhem I; Einarsson K
J Lipid Res; 1990 Dec; 31(12):2219-26. PubMed ID: 2090716
[TBL] [Abstract][Full Text] [Related]
25. Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methylglutaryl CoA reductase and cholesterol 7alpha-hydroxylase in the rat.
Shefer S; Hauser S; Lapar V; Mosbach EH
J Lipid Res; 1973 Sep; 14(5):573-80. PubMed ID: 4729973
[TBL] [Abstract][Full Text] [Related]
26. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
Okamoto S; Nakano K; Kosahara K; Kishinaka M; Oda H; Ichimiya H; Chijiiwa K; Kuroki S
J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
[TBL] [Abstract][Full Text] [Related]
27. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase.
Ståhlberg D; Reihnér E; Rudling M; Berglund L; Einarsson K; Angelin B
Hepatology; 1995 Apr; 21(4):1025-30. PubMed ID: 7705775
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat.
Rudling M; Parini P; Angelin B
J Clin Invest; 1997 May; 99(9):2239-45. PubMed ID: 9151797
[TBL] [Abstract][Full Text] [Related]
29. Bile acid synthesis. VI. Regulation of cholesterol 7 alpha-hydroxylase by taurocholate and mevalonate.
Pandak WM; Vlahcevic ZR; Chiang JY; Heuman DM; Hylemon PB
J Lipid Res; 1992 May; 33(5):659-68. PubMed ID: 1619360
[TBL] [Abstract][Full Text] [Related]
30. SC-435, an ileal apical sodium-codependent bile acid transporter inhibitor alters mRNA levels and enzyme activities of selected genes involved in hepatic cholesterol and lipoprotein metabolism in guinea pigs.
West KL; McGrane M; Odom D; Keller B; Fernandez ML
J Nutr Biochem; 2005 Dec; 16(12):722-8. PubMed ID: 16169202
[TBL] [Abstract][Full Text] [Related]
31. Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action.
Maton PN; Murphy GM; Dowling RH
Lancet; 1977 Dec 24-31; 2(8052-8053):1297-301. PubMed ID: 74722
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model.
Pearlman BJ; Bonorris GG; Phillips MJ; Chung A; Vimadalal S; Marks JW; Schoenfield LJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):634-41. PubMed ID: 467920
[TBL] [Abstract][Full Text] [Related]
33. Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase.
Pandak WM; Vlahcevic ZR; Heuman DM; Redford KS; Chiang JY; Hylemon PB
Hepatology; 1994 Apr; 19(4):941-7. PubMed ID: 8138269
[TBL] [Abstract][Full Text] [Related]
34. Hamsters predisposed to sucrose-induced cholesterol gallstones (LPN strain) are more resistant to excess dietary cholesterol than hamsters that are not sensitive to cholelithiasis induction.
Souidi M; Combettes-Souverain M; Milliat F; Eckhardt ER; Audas O; Dubrac S; Parquet M; Férézou J; Lutton C
J Nutr; 2001 Jun; 131(6):1803-11. PubMed ID: 11385071
[TBL] [Abstract][Full Text] [Related]
35. Increased bile acid concentration in liver tissue with cholesterol gallstone disease.
Honda A; Yoshida T; Tanaka N; Matsuzaki Y; He B; Shoda J; Osuga T
J Gastroenterol; 1995 Feb; 30(1):61-6. PubMed ID: 7719416
[TBL] [Abstract][Full Text] [Related]
36. Effects of gender on hepatic HMG-CoA reductase, cholesterol 7alpha-hydroxylase, and LDL receptor in hereditary analbuminemia.
Shin Y; Vaziri ND; Willekes N; Kim CH; Joles JA
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E993-8. PubMed ID: 16030068
[TBL] [Abstract][Full Text] [Related]
37. Prevention of cholesterol-induced gallstones by hyodeoxycholic acid in the prairie dog.
Singhal AK; Cohen BI; Mosbach EH; Une M; Stenger RJ; McSherry CK; May-Donath P; Palaia T
J Lipid Res; 1984 Jun; 25(6):539-49. PubMed ID: 6747458
[TBL] [Abstract][Full Text] [Related]
38. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
39. Bile acid synthesis and biliary hydrophobicity during obstructive jaundice in rats.
Naito T; Kuroki S; Chijiiwa K; Tanaka M
J Surg Res; 1996 Sep; 65(1):70-6. PubMed ID: 8895609
[TBL] [Abstract][Full Text] [Related]
40. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
